Cover Image
市場調查報告書

代謝體學市場:各技術(氣相層析法,高速液體層析法,核磁共振光譜學,質譜分析),各用途(生物標記及藥物研發,營養基因學),各適應症(腫瘤,心臟)的全球市場預測

Metabolomics Market by Technique, Application & by Indication- Global Forecast to 2019

出版商 MarketsandMarkets 商品編碼 259317
出版日期 內容資訊 英文 306 Pages
訂單完成後即時交付
價格
Back to Top
代謝體學市場:各技術(氣相層析法,高速液體層析法,核磁共振光譜學,質譜分析),各用途(生物標記及藥物研發,營養基因學),各適應症(腫瘤,心臟)的全球市場預測 Metabolomics Market by Technique, Application & by Indication- Global Forecast to 2019
出版日期: 2014年06月26日 內容資訊: 英文 306 Pages
簡介

代謝體學是研究與代謝相關的科學過程,使用層析法和光譜學、核磁共振、毛細管電泳法等各種分析技術。代謝體學目前廣泛用於醫藥品產業和生物科技產業的生物標記和藥物研發等領域。全球代謝體學市場被大型企業佔了市場的70%-75%,由於許多新企業的加入,預測與既有企業的競爭將會激烈化。

本報告提供全球代謝體學市場相關調查,提供您各技術,各用途,各適應症,各地區的趨勢,彙整競爭環境,及參與企業簡介等。

第1章 簡介

第2章 摘要整理

第3章 高級見解

第4章 市場概要

  • 簡介
    • 代謝體學和Metabonomics
    • 代謝體學的概念方法
  • 市場趨勢
  • 促進要素
  • 阻礙要素
  • 機會
  • 趨勢

第5章 技術投資

  • 簡介
  • 投資機關
  • 使用了策略性評估的技術性投資的潛在領域
  • 技術藍圖

第6章 代謝體學市場:各技術

  • 分離技術
    • 氣相層析法
    • 毛細管電泳法
    • 高速液體層析法
    • 超高速液體層析法
  • 檢測技術
    • 核磁共振光譜學
    • 質譜分析
    • 表面質譜分析

第7章 代謝體學市場:各用途

  • 生物標記藥物研發
  • 藥物研發/藥物評估
  • 毒性檢驗
  • 營養基因學
  • 其他

第8章 代謝體學市場:各適應症

  • 腫瘤
  • 心臟
  • 神經
  • 其他

第9章 代謝體學市場:各地區分析

  • 北美
  • 歐洲
  • 亞太地區
  • 其他各國

第10章 競爭環境

  • 新產品上市
  • 協定,聯盟,聯合,合資企業
  • 合併·收購
  • 其他

第11章 企業簡介

  • Agilent Technologies
  • Biocrates Life Sciences AG
  • Bruker Corporation
  • Danaher Corporation
  • Human Metabolomics Technologies, Inc.
  • LECO Corporation
  • Metabolon, Inc.
  • 株式會社島津製作所
  • Thermo Fisher Scientific Inc (Life Technologies + Prionics AG)
  • Waters Corporation

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: BT 2550

In this report, the global metabolomics market is segmented based on techniques, applications, indications, and geography. Based on techniques, the metabolomics market is classified into Gas Chromatography, High Performance Liquid Chromatography (HPLC), Ultra Performance Liquid Chromatography (UPLC), Nuclear Magnetic Resonance Spectroscopy (NMR), Mass Spectrometry (MS), and Surface-based Mass Analysis. The application market covers biomarker discovery, drug discovery/drug assessment, toxicology testing, nutrigenomics, and others. This report also discusses the key market drivers, restraints, and opportunities in the global metabolomics market and its sub-markets.

The global metabolomics market is expected to grow at a strong CAGR during the forecast period of 2014 to 2019 and is estimated to be worth $2,100 million by 2019. The market is mainly driven by the increasing research funding for metabolomics from governments and private investors, growing demand for personalized medicine in the U.S. and Europe, and the increasing need for toxicology testing. However, low adoption rates and data complexity inhibit the growth of the market to a certain extent.

During the forecast period, the high performance liquid chromatography (HPLC) segment will continue to drive and dominate the metabolomics market. The large share of the HPLC segment can be attributed to its wide application in biomarker discovery. By 2018, North America will continue to drive and dominate the metabolomics market, primarily due to the presence of major metabolomics companies in the U.S. Majority of the growth in the Asia-Pacific region is primarily driven by the growing pharmaceutical and biotechnology industries in this region. Developing technologies in Japan and China for drug discovery and early diagnosis of various diseases are expected to aid the growth of the APAC metabolomics market.

The major players in the metabolomics market include Thermo Fisher Scientific, Inc. (U.S.), Danaher Corporation (U.S.), Waters Corporation (U.S.), Agilent Technologies (U.S.), Metabolon, Inc. (U.S.), Shimadzu Corporation (Japan), Bruker Corporation (U.S.), and Biocrates Life Sciences AG. (Austria). Collectively, the top five players accounted for nearly 75% of the global metabolomics market in 2013.

Thermo Fisher Scientific, Inc. (U.S.) and Danaher Corporation (U.S.) are the leading players in the market which together accounted for a share of around 40% to 45% in 2013. Thermo Fisher Scientific has a diversified product portfolio, which includes a wide range of analytical products, including liquid chromatography and gas chromatography systems. The company has a strong presence in over 150 countries through its strong manufacturing and distribution facilities, which enables it to cater to a large customer base across the globe. It focuses on strengthening and streamlining its product portfolio for the metabolomics market.

Reasons to Buy the Report

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the market which in turn would help the firms in garnering a greater market share. Firms purchasing this report could use any one or combination of the below mentioned five strategies (Market Penetration, Product Development/Innovation, Market Development, Market Diversification, and Competitive Assessment) for reaping a greater market share.

This report provides insights on the following pointers:

  • Market Penetration: Comprehensive information on product portfolios offered by the top players in the metabolomics market. The report analyzes the metabolomics market by technique, application, and indication across all regions.
  • Product Development/Innovation: Detailed insights on the upcoming trends, research and development activities, and new product launches in the metabolomics market.
  • Market Development: Comprehensive information on the lucrative emerging markets by technique, application, indication, and geography.
  • Market Diversification: Exhaustive information of new products, growing regions, recent developments, and investments in the metabolomics market.
  • Competitive Assessment: In-depth assessment of market shares, growth strategies, products, distribution networks, manufacturing capabilities, and SWOT analyses of the leading players in the metabolomics market.

Table of Contents

1. Introduction

  • 1.1. Key Take-Aways
  • 1.2. Report Description
  • 1.3. Markets Covered
  • 1.4. Stakeholders
  • 1.5. Research Methodology
  • 1.6. Market Size Estimation
  • 1.7. Market crackdown and Data Triangulation
  • 1.8. Market Forecasting Model
  • 1.9. Key Data Point Taken from Secondary Sources
  • 1.10. Key Data Point Taken from Primary Sources

2. Executive Summary

3. Premium Insights

4. Market Overview

  • 4.1. Introduction
    • 4.1.1. Metabolomics Vs Metabonomics
    • 4.1.2. Conceptual Approach in Metabolomics
      • 4.1.2.1. Target Analysis
      • 4.1.2.2. Metabolite Profiling
      • 4.1.2.3. Metabolomic Fingerprinting
  • 4.2. Market Dynamics
  • 4.3. Drivers
    • 4.3.1. Research Funding and government support spurs the market growth
    • 4.3.2. Biotechnology & Pharmaceutical Sectors Drive Metabolomics Research
    • 4.3.3. Increasing demand for personalized medicine in healthcare industry
    • 4.3.4. Increased Necessity for Toxicity Technologies
  • 4.4. Restrains
    • 4.4.1. Data Processing & Analysis
    • 4.4.2. Low Adoption Rate
  • 4.5. Opportunities
    • 4.5.1. Untapped Emerging Market
    • 4.5.2. Biomarker Discovery Services
  • 4.6. Trends
    • 4.6.1. Technological Advancements
    • 4.6.2. Integration Of Research Universities With Market Players

5. Technology Investment Potential

  • 5.1. Introduction
  • 5.2. Funding Bodies
  • 5.3. Analysis of Potential Areas for Technology Investment using Strategic Evaluation
  • 5.4. Technology Roadmap

6. Metabolomics Market, by Technique

  • 6.1. Separation Techniques
    • 6.1.1. Gas Chromatography (GC)
    • 6.1.2. Capillary Electrophoresis (CE)
    • 6.1.3. High Performance Liquid Chromatography (HPLC)
    • 6.1.4. Ultra Performance Liquid Chromatography (UPLC)
  • 6.2. Detection Techniques
    • 6.2.1. Nuclear Magnetic Resonance Spectroscopy (NMR)
    • 6.2.2. Mass Spectrometry (MS)
    • 6.2.3. Surface Based Mass Analysis

7. Metabolomics Market, by Application

  • 7.1. Biomarker Discovery
  • 7.2. Drug Discovery/Drug Assessment
  • 7.3. Toxicology Testing
  • 7.4. Nutrigenomics
  • 7.5. Others

8. Metabolomics Market, by Indication

  • 8.1. Oncology
  • 8.2. Cardiology
  • 8.3. Neurology
  • 8.4. Others

9. Metabolomics Market, by Geography

  • 9.1. North America
    • 9.1.1. U.S.
    • 9.1.2. Canada
  • 9.2. Europe
    • 9.2.1. Germany
    • 9.2.2. U.K.
    • 9.2.3. France
    • 9.2.4. Spain
    • 9.2.5. Italy
    • 9.2.6. Rest of Europe
  • 9.3. Asia-Pacific
    • 9.3.1. Japan
    • 9.3.2. China
    • 9.3.3. India
    • 9.3.4. Rest of Asia-Pacific
  • 9.4. Rest of the World (RoW)
    • 9.4.1. Latin America
    • 9.4.2. Middle East

10. Competitive Landscape

  • 10.1. New Product Launches
  • 10.2. Agreements/Partnerships/Collaborations/Joint Ventures
  • 10.3. Mergers and Acquisitions
  • 10.4. Other Developments

11. Company Profiles

  • 11.1. Agilent Technologies
    • 11.1.1. Business Overview
    • 11.1.2. Products & Services
    • 11.1.3. Key Financials
    • 11.1.4. Growth Strategy
    • 11.1.5. Recent Developments
    • 11.1.6. SWOT Analysis
    • 11.1.7. MNM View
  • 11.2. Biocrates Life Sciences AG
  • 11.3. Bruker Corporation
  • 11.4. Danaher Corporation
  • 11.5. Human Metabolomics Technologies, Inc.
  • 11.6. LECO Corporation
  • 11.7. Metabolon, Inc.
  • 11.8. Shimadzu Corporation
  • 11.9. Thermo Fisher Scientific Inc (Life Technologies + Prionics AG)
  • 11.10. Waters Corporation

List of Tables

  • Table 1: Global Metabolomics Market, By Technique Market , by Geography, 2012-2019 ($Million)
  • Table 2: Global Metabolomics Seperation technique Market , by Technique, 2012-2019 ($Million)
  • Table 3: Global Metabolomics Separation technique Market , by Geography, 2012-2019 ($Million)
  • Table 4: Global Metabolomics Detection technique Market , by Geography, 2012-2019 ($Million)
  • Table 5: Global Gas Chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 6: Global Capillary Electrophoresis Market , by Geography, 2012-2019 ($Million)
  • Table 7: Global High Performance liquid chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 8: Global Ultra performance liquid chromatography Market , by Geography, 2012-2019 ($Million)
  • Table 9: Global Nuclear Magnetic Resonance Spectroscopy Market , by Geography, 2011-2018 ($Million)
  • Table 10: Global Mass Spectrometry Market, by Geography, 2012-2019 ($Million)
  • Table 11: Global Surface Based Mass Analysis Market , by Geography, 2012-2019 ($Million)
  • Table 12: Global Metabolomics Market , by Indication, 2012-2019 ($Million)
  • Table 13: Global Metabolomics Oncology Market , by Geography, 2012-2019 ($Million)
  • Table 14: Global Metabolomics Cardiology Market , by geography, 2012-2019 ($Million)
  • Table 15: Global Metabolomics Neurology Market , by Geography, 2012-2019 ($Million)
  • Table 16: Global Metabolomics Other Indications Market , by Geography, 2012-2019 ($Million)
  • Table 17: Global Metabolomics Market , by application, 2012-2019 ($Million)
  • Table 18: Global Metabolomics Biomarker Discovery Market , by Geography, 2012-2019 ($Million)
  • Table 19: Global Metabolomics Drug Discovery Market , by geography, 2012-2019 ($Million)
  • Table 20: Global Metabolomics Toxicology Testing Market , by Geography, 2012-2019 ($Million)
  • Table 21: Global Metabolomics Mutrigenomics Market , by Geography, 2012-2019 ($Million)
  • Table 22: Global Metabolomics Other Applications Market , by Geography, 2012-2019 ($Million)
  • Table 23: North America: Metabolomics Market, By Country , 2012-2019 ($Million)
  • Table 24: North America: Metabolomics Market, By technique, 2012-2019 ($Million)
  • Table 25: North America: Market, By application, 2012-2019 ($Million)
  • Table 26: North America: Metabolomics Market, By indication, 2012-2019 ($Million)
  • Table 27: U.S.: Metabolomics Market, By Technique, 2012-2019 ($Million)
  • Table 28: U.S.: Market, By Application, 2012-2019 ($Million)
  • Table 29: U.S.: Metabolomics Market, By Indication , 2012-2019 ($Million)
  • Table 30: Canada: Metabolomics Market, By Technique, 2012-2019 ($Million)
  • Table 31: Canada: Market, By Application, 2012-2019 ($Million)
  • Table 32: Canada: Market, By Indication, 2012-2019 ($Million)
  • Table 33: Europe: Metabolomics Market, By Country , 2012-2019 ($Million)
  • Table 34: Europe: Market, By Technique , 2012-2019 ($Million)
  • Table 35: Europe: Market, By application, 2012-2019 ($Million)
  • Table 36: Europe: Market, By Indication, 2012-2019 ($Million)
  • Table 37: U.K.: Metabolomics Mrket, By technique , 2012-2019 ($Million)
  • Table 38: U.K.: Metabolomics Market, By Application, 2012-2019 ($Million)
  • Table 39: U.K.: Market, By Indication, 2012-2019 ($Million)
  • Table 40: Germany: Metabolomics Market, By technique , 2012-2019 ($Million)
  • Table 41: Germany: Market, By Application, 2012-2019 ($Million)
  • Table 42: Germany: Market, By Indication, 2012-2019 ($Million)
  • Table 43: France: Market, By Technique, 2012- 2019($Million)
  • Table 44: France: Metabolomics Market, By Application, 2012- 2019($Million)
  • Table 45: France: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 46: Italy: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 47: Italy: Market, By Application , 2012- 2019($Million)
  • Table 48: Italy: Market, By Indication , 2012- 2019($Million)
  • Table 49: Spain: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 50: Spain: Market, By Application , 2012- 2019($Million)
  • Table 51: Spain: Market, By Indication , 2012- 2019($Million)
  • Table 52: ROE: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 53: ROE: Metabolomics Market, By Application , 2012- 2019($Million)
  • Table 54: ROE: Market, By Indication , 2012- 2019($Million)
  • Table 55: Asia_Pacific Metabolomics Market, By Country , 2012- 2019($Million)
  • Table 56: Asia_Pacific: Market, By Technique , 2012- 2019($Million)
  • Table 57: Asia_Pacific: Market, By Application , 2012- 2019($Million)
  • Table 58: Asia_Pacific: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 59: Japan: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 60: Japan: Market, By Application , 2012- 2019($Million)
  • Table 61: Japan: Market, By Indication , 2012- 2019($Million)
  • Table 62: China: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 63: China: Market, By Application , 2012- 2019($Million)
  • Table 64: China: Metabolomics Market, By Indication , 2012- 2019($Million)
  • Table 65: India: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 66: India: Market, By Application , 2012- 2019($Million)
  • Table 67: India: Market, By Indication , 2012- 2019($Million)
  • Table 68: RoAPAC: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 69: RoAPAC: Metabolomics Market, By Application , 2012- 2019($Million)
  • Table 70: RoAPAC: Market, By Indication , 2012- 2019($Million)
  • Table 71: RoW: Metabolomics Market, By Country , 2012- 2019($Million)
  • Table 72: RoW: Market, By Technique , 2012- 2019($Million)
  • Table 73: RoW: Market, By Application , 2012- 2019($Million)
  • Table 74: RoW: Market, By Indication , 2012- 2019($Million)
  • Table 75: Latin America: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 76: Latin America: Market, By Application , 2012- 2019($Million)
  • Table 77: Latin America: Market, By Indication , 2012- 2019($Million)
  • Table 78: Middle East: Metabolomics Market, By Technique , 2012- 2019($Million)
  • Table 79: Middle East: Market, By Application , 2012- 2019($Million)
  • Table 80: Middle East: Market, By Indication , 2012- 2019($Million)

List of Figures

  • Figure 1: Research methodology
  • Figure 2: Market Size Estimation Methodology
  • Figure 3: DATA Triangulation Methodology
  • Figure 4: Global Metabolomics Technique Market, 2014 VS. 2019 ($Milliion)
  • Figure 5: Global Market for Companion Animals, 2013 VS. 2018 ($Milliion)
  • Figure 6: Metabolomics Market: High-Growth Markets, 2013
  • Figure 7: Market Dynamics of Global Market
Back to Top